Slide 1: Premium non-invasive cardiovascular monitoring for global medical markets
For personal use only Premium non-invasive cardiovascular monitoring for global medical markets September Update Expanding revenues – Building towards profitability Rob Phillips PhD(med), MPhil(med), FASE, DMU(cardiol) Executive Chairman & Chief Executive Officer September 2014 Uscom - The measure o
Slide 2: Important Notice
Important Notice For personal use only This Investor Presentation contains confidential information regarding Uscom and its affiliates. The information contained in this Investor Presentation is believed to be reliable. No assurance is given as to the accuracy or completeness of such information Thi
Slide 3: Message
Message For personal use only “Uscom is focused on growth Two real, practice changing cardiovascular devices selling into massive global medical markets Immediate mission is grow distribution, sales and revenue Strategic view of the future” 3 Uscom - The measure of life
Slide 4: Corporate Snap Shot
Corporate Snap Shot For personal use only Corporate Board • ASX listed (ticker UCM) • Rob Phillips (Chairman & Founder) • Headquartered in Sydney • Sheena Jack (HCF, Moneytime Health) • Market cap ~$22m (29 Aug 14) • Christian Bernecker (Nightingale Partners, Stream) Financials • FY14 Revenue $1.1m
Slide 5: Investment Overview
Investment Overview For personal use only • Premium cardiovascular device company poised for global growth • Two platform technologies with revenue and un-recognised value • Demonstrable benefits over existing technology – saves lives • Strong margin, low capex business model • Distributors in key o
Slide 6: Our Business
Our Business For personal use only • Uscom manufactures and sells two, proprietary, FDA/CE approved premium cardiovascular monitoring products – USCOM 1A and Uscom BP+ measuring cardiac output and central blood pressure • USCOM – Cardiac Output • Customers are hospitals, emergency, ICU, anesthesia,
Slide 7: US$3b Global Market opportunity
US$3b Global Market opportunity For personal use only USCOM 1A Market “the global physiology monitoring market was valued at USD $1.3b in 2012 with an estimated CAGR of 7.6% from 2013 to 2019.” BP+ Market “the global blood pressure monitoring testing market was valued at USD $1.7b in 2012 and is est
Slide 8: Ultra-Sound Cardiac Monitor (USCOM 1A)
Ultra-Sound Cardiac Monitor (USCOM 1A) For personal use only Non invasive, accurate, compact technology platform solution Accurate cardiac output Works with all other hospital equipment Cardiac stroke volume Intuitive touch screen Systemic vascular resistance Real time data Left + right heart Platfo
Slide 9: USCOM 1A – clinically accepted technology
USCOM 1A – clinically accepted technology For personal use only Featured in 350+ peer reviewed publications and presentations Sepsis, Heart failure, Hypertension, Fluid management, Emergency, Pediatrics, Cardiac transplantation, Electrophysiology, Emergency transport, Anesthesia, Liver transplantati
Slide 10: USCOM1A Competitive Advantages
USCOM1A Competitive Advantages For personal use only Rel+Re Non- SV beat Method Manufacturer Technology p invasive Simple Cost Portable to beat USCOM 1A Uscom Doppler ✓ ✓ ✓ ✓ ✓ ✓ BioZ Sonosite BioImpedance ✗ ✓ ✓ ✗ ✓ ✗ NiCOM Cheetah BioReactance ✗ ✓ ✓ ✗ ✓ ✗ Nexfin Bmeye APP ✗ ✓ ✓ ✓ ✓ ✗ CardioQ Deltex
Slide 11: Central BP+
Central BP+ For personal use only New Wave Supra-systolic Oscillometry Central Blood Pressure and Pulse Pressure Wave Analysis FDA, CE Mark, TGA approvals Home or clinical use Supra-systolic PPW Analysis Central BP+ Results in Reliable and 30 seconds accurate No training Central and required Brachia
Slide 12: BP+ - Superior BP measurement
BP+ - Superior BP measurement For personal use only + Other BP devices + + Heart Vessels + Blood Pressure Plus… demonstrating what others cant! 12 Uscom - The measure of life
Slide 13: Competitive Advantages cBP
Competitive Advantages cBP For personal use only Uscom BP+ TensioMed BPLab IEM Centron AtCor Australia Hungary Russia Germany UK Australia USD 3,950 USD 6,000 USD 7,000 USD 7,000 USD 6,300 USD 14,000 1 min 2 min 2 min 2 min 1 min 1 min Stand-alone ABP, needs ABP, needs ABP, needs Stand-alone Needs c
Slide 14: Why?
Why ? For personal use only Independent published research by University of Cambridge – Benefits of measuring central blood pressure 14 Uscom - The measure of life
Slide 15: Broad patent portfolio
Broad patent portfolio For personal use only Core technology protected by granted patents – patents run to 2024 and beyond USCOM 1A BP+ 22 granted patents 34 granted patents 5 pending applications 4 registered trade marks 2 registered trade marks 15 Uscom - The measure of life
Slide 16: Distribution Focus
Distribution Focus For personal use only New Global Sales Manager Pioneer Medical – China BP+ Deltex Medical – USCOM 1A Unetixs – Strategic cardiovascular USA USCOM 1A 30 distributors – increased by 13 New support and training New performance monitoring On going strategic discussions – OEM, Licensin
Slide 17: BP+ – China Distribution
BP+ – China Distribution For personal use only New 5 year, A$7m distribution deal 510 Regional Distributors 20,000+ Hospitals Every Region in China Hemodynamics. Fluid. Innovation. 17 Uscom - The measure of life
Slide 18: Experienced management team
Experienced management team For personal use only Rob Phillips • Founder and inventor of the USCOM1A Executive Chairman & CEO • Recognised leader and innovator in the field of non-invasive cardiovascular monitoring with multiple peer review papers • Detailed knowledge of the platform and its applica
Slide 19: Recent Achievements / Targeted Milestones
Recent Achievements / Targeted Milestones For personal use only • Operations – Revenues from activities up 67%, and cash on hand up 292% • Growth – Successful integration of Pulsecor IP, systems and assets • Milestones - Manufacture and sale of the first Uscom BP+, new USA BP+ patent, and CE approva
Slide 20: Broker Research – April 2014
Broker Research – 3 April 2014 For personal use only 20 Uscom - The measure of life
Slide 21: APPENDICES
For personal use only APPENDICES 21 Uscom - The measure of life
Slide 22: Independent published research – identifies BP+ most clinically applicable cBP monitor
For personal use only Independent published research – identifies BP+ most clinically applicable cBP monitor McEniery CM, Cockcroft JR, Roman MJ, Franklin SS, Wilkinson AB. Central blood pressure: current evidence and clinical importance. Euro Heart J 2014;doi10.1093/eurojeartj/eht565 22 Uscom - The
Slide 23: Testimonials
Testimonials “This machine is saving lives, there are no two ways about it.” Professor Brendan Smith, Anesthetist, Intensivist and Emergency Physician, N.S.W. Dept of Health, Australia For personal use only “USCOM has changed the way I look at the cardiovascular status of my patients. It’s part of t
Slide 24: New Science - USCOM Saving Lives
New Science - USCOM Saving Lives For personal use only National ICU Study – Sepsis and septic shock mortality 6yr Australian Practice Audit ANZICS CORE Adult database 30 Bathurst USCOM 25 Australia 20 Australian Rural 15 10 BUSH protocol introduced 5 0 2006 2007 2008 2009 2010 2011 2012 Smith BE, Ph
Slide 25: New Science - USCOM Reducing Costs
New Science - USCOM Reducing Costs For personal use only National ICU Study – 6yr Australian Practice Audit ANZICS CORE Adult database Mean Cost per Admission 2007-2012 $60,000 $48,000 $50,000 $41,645 $40,000 $30,000 $26,273 $20,000 $10,000 $0 Australian Australian Rural BUSH Mean cost per hospitali
Slide 26: Risk factors
Risk factors For personal use only • Global medical markets unpredictable • Product development /regulatory approvals slower and more costly than expected • Distribution slow to achieve revenue goals • Competitive threats • Patent breaches • Currently not profitable 26 Uscom - The measure of life